-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nonalcoholic fatty liver disease (NAFLD) is a widespread disease associated with increased mortality
.
In addition, NAFLD is associated with type 2 diabetes , insulin resistance, chronic inflammation, low physical activity, and vitamin D deficiency, which may lead to decreased bone density
Diabetes Vitamin D Osteoporosis
The aim of this study was to determine fracture incidence, fracture risk, and post-fracture mortality in patients with NAFLD compared with the general population
.
This is a population-based nationwide cohort study using data from the Swedish National Patient Registry of 10,678 patients with NAFLD from 1987-2016
.
Patients were matched for sex, age, and city with 99,176 controls from the Swedish General Population Register
A total of 12,312 fractures occurred during 761,176 person-years of follow-up
.
NAFLD patients (17.
CONCLUSIONS: Patients with NAFLD have a slightly higher incidence of fractures, but the long-term risk of fractures is comparable to the general population
.
This suggests that extensive monitoring of fracture risk factors in NAFLD patients is unnecessary
Fracture rates are slightly higher in NAFLD patients, but the long-term risk of fractures is comparable to the general population
Original source:
Axel Wester, et al.
Axel Wester, et al.
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: Anationwide population-based cohort study .
Journal of Internal Medicine.
2022.
https://onlinelibrary.
wiley.
com/doi/10.
1111/joim.
13497 Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: Anationwide population-based cohort study Leave a comment here